Regeneron Pharmaceuticals, Inc. (REGN)
741.22
+1.65
(+0.22%)
USD |
NASDAQ |
Oct 09, 09:41
Regeneron Pharmaceuticals 30-Day Average Daily Volume : 720681.1 for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 720681.1 |
| October 07, 2026 | 723516.9 |
| October 06, 2026 | 719483.3 |
| October 05, 2026 | 721381.7 |
| October 02, 2026 | 724444.8 |
| October 01, 2026 | 723862.3 |
| September 30, 2026 | 714114.9 |
| September 29, 2026 | 711002.1 |
| September 28, 2026 | 702234.5 |
| September 25, 2026 | 678093.4 |
| September 24, 2026 | 682013.4 |
| September 23, 2026 | 681097.1 |
| September 22, 2026 | 688366.4 |
| September 21, 2026 | 708817.5 |
| September 18, 2026 | 713253.2 |
| September 17, 2026 | 656937.0 |
| September 16, 2026 | 651259.2 |
| September 15, 2026 | 665737.1 |
| September 14, 2026 | 675800.2 |
| September 11, 2026 | 694709.8 |
| September 10, 2026 | 728609.0 |
| September 09, 2026 | 745126.0 |
| September 08, 2026 | 754424.3 |
| September 04, 2026 | 757572.6 |
| September 03, 2026 | 762480.0 |
| Date | Value |
|---|---|
| September 02, 2026 | 783585.2 |
| September 01, 2026 | 787675.8 |
| August 31, 2026 | 782575.0 |
| August 28, 2026 | 773592.4 |
| August 27, 2026 | 778928.9 |
| August 26, 2026 | 777704.1 |
| August 25, 2026 | 776705.8 |
| August 24, 2026 | 775791.3 |
| August 21, 2026 | 773601.0 |
| August 20, 2026 | 766762.9 |
| August 19, 2026 | 769298.0 |
| August 18, 2026 | 769177.6 |
| August 17, 2026 | 773839.7 |
| August 14, 2026 | 779607.5 |
| August 13, 2026 | 801140.9 |
| August 12, 2026 | 816504.6 |
| August 11, 2026 | 824696.6 |
| August 10, 2026 | 817874.6 |
| August 07, 2026 | 817869.1 |
| August 06, 2026 | 813177.9 |
| August 05, 2026 | 815044.0 |
| August 04, 2026 | 839956.9 |
| August 03, 2026 | 866190.8 |
| July 31, 2026 | 925075.1 |
| July 30, 2026 | 929778.7 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Gilead Sciences, Inc. | 5.591M |
| Alnylam Pharmaceuticals, Inc. | 1.503M |
| Amgen, Inc. | 2.956M |
| Incyte Corp. | 1.595M |
| Vertex Pharmaceuticals, Inc. | 1.013M |